ALBT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Avalon Globocare Corp (ALBT) is not a good buy for a beginner, long-term investor at this time. The stock is experiencing significant negative price momentum, weak financial performance, and lacks any positive catalysts or trading signals to suggest a strong entry point. Additionally, no significant insider, hedge fund, or congress trading activity has been observed to support a bullish sentiment.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is at 25.529, which is neutral but leaning towards oversold territory. Moving averages are converging, showing no clear trend. The price is currently below the key pivot level (0.728) and approaching the first support level (0.569), suggesting bearish sentiment.
NULL. No recent news, no significant insider or hedge fund activity, and no congress trading data.
The stock experienced a significant regular market drop of -20.15%, with additional post-market decline of -1.37%. Financial performance in Q3 2025 showed a sharp decline in net income (-84.86% YoY) and EPS (-96.70% YoY), indicating poor profitability. No positive trading signals from AI Stock Picker or SwingMax.
In Q3 2025, revenue increased by 1.43% YoY to $350,099, but net income dropped significantly by -84.86% YoY to -$254,268. EPS fell drastically by -96.70% YoY to -0.06. Gross margin improved by 14.51% YoY to 33.06%, but overall financials indicate poor profitability and weak growth.
No analyst rating or price target data available.
